Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -34.67% is 68% above its 4-year average of -107.05%, near the high end of its 4-year range (-271.23%–-26.49%).
As of the fiscal period ended Tuesday, June 30, 2026. 38.94% above its 12-month average of -56.78%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -34.67%.
RETURN ON EQUITY (ROE)
-34.67%
RETURN ON EQUITY (ROE) AVG TTM
-56.78%
RETURN ON EQUITY (ROE) AVG 3Y
-104.27%
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+38.94%
CURRENT VS 3Y AVG
+66.75%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-38.25%
median of 444 covered companies
CURRENT VS SECTOR MEDIAN
+9.37%
vs the sector median at left
Healthcare Triangle, Inc.
Market Cap
$9.09M
Return on Equity (ROE)
-34.67%
TTM Avg
-56.78%
3Y Avg
-104.27%
5Y Avg
N/A
Market Cap
$8.83M
Return on Equity (ROE)
-7.36%
TTM Avg
-85.10%
3Y Avg
-73.72%
5Y Avg
-96.61%
Market Cap
$9.42M
Return on Equity (ROE)
N/A
TTM Avg
-2138.11%
3Y Avg
-1780.63%
5Y Avg
-1152.40%
Market Cap
$9.63M
Return on Equity (ROE)
-2248.48%
TTM Avg
-970.82%
3Y Avg
-532.13%
5Y Avg
-347.08%
Market Cap
$9.94M
Return on Equity (ROE)
-440.15%
TTM Avg
-145.56%
3Y Avg
-96.97%
5Y Avg
-42.16%
Market Cap
$8.42M
Return on Equity (ROE)
-31.99%
TTM Avg
-84.19%
3Y Avg
-171.49%
5Y Avg
-138.23%
Market Cap
$10.07M
Return on Equity (ROE)
-317.20%
TTM Avg
510.39%
3Y Avg
317.15%
5Y Avg
239.40%
Market Cap
$10.27M
Return on Equity (ROE)
-506.63%
TTM Avg
-300.20%
3Y Avg
-300.20%
5Y Avg
-300.20%
Market Cap
$7.77M
Return on Equity (ROE)
-618.74%
TTM Avg
149.09%
3Y Avg
4.64%
5Y Avg
-24.92%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Healthcare Triangle, Inc. (HCTI) | $9.09M | -34.67% | -56.78% | -104.27% | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $8.83M | -7.36% | -85.10% | -73.72% | -96.61% |
| HeartSciences Inc. (HSCS)vs › | $9.42M | N/A | -2138.11% | -1780.63% | -1152.40% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.63M | -2248.48% | -970.82% | -532.13% | -347.08% |
| Ainos, Inc. (AIMD)vs › | $9.94M | -440.15% | -145.56% | -96.97% | -42.16% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.42M | -31.99% | -84.19% | -171.49% | -138.23% |
| SeaStar Medical Holding Corporation (ICU)vs › | $10.07M | -317.20% | 510.39% | 317.15% | 239.40% |
| Caring Brands, Inc. (CABR)vs › | $10.27M | -506.63% | -300.20% | -300.20% | -300.20% |
| GT Biopharma, Inc. (GTBP)vs › | $7.77M | -618.74% | 149.09% | 4.64% | -24.92% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | -91.75% | -295.51% | -88.38% | -106.70% |
ROE
-34.7%
ROA
-23.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -34.67% |
| 2026-03-31 | -26.49% |
| 2025-12-31 | -94.94% |
| 2025-09-30 | -72.30% |
| 2025-06-30 | -55.49% |
| 2025-03-31 | -67.70% |
| 2023-09-30 | -271.23% |
| 2023-06-30 | -211.33% |
| 2023-03-31 | -168.04% |
| 2022-12-31 | -237.85% |
| 2022-09-30 | -46.66% |
| 2022-06-30 | -55.68% |
| 2022-03-31 | -49.29% |
